Cdk2 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdk2 monoclonal antibodies for research in cell cycle regulation and related pathways. Cdk2 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyclin-dependent kinase 2 (Cdk2) plays a crucial role in the regulation of the cell cycle, particularly in the transition from the G1 phase to the S phase, where DNA replication occurs. Dysregulation of Cdk2 activity has been implicated in various cancers, making it a significant target for therapeutic intervention. Understanding the function and regulation of Cdk2 is essential for elucidating the mechanisms of cell proliferation and tumorigenesis. Cdk2 monoclonal antibodies enable researchers to investigate protein-protein interactions and signaling pathways involved in cell cycle control. Studying Cdk2 expression patterns and activity levels helps reveal its role in normal cellular processes and disease states. The specificity and reliability of Cdk2 monoclonal antibodies support breakthrough discoveries in cancer research and cell biology. Santa Cruz Biotechnology monoclonal antibodies for Cdk2 empower researchers worldwide to advance scientific understanding of cell cycle regulation and its impact on human health.